119 related articles for article (PubMed ID: 24344235)
41. Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.
Wang F; Stappenbeck F; Matsui W; Parhami F
J Cell Biochem; 2017 Mar; 118(3):499-509. PubMed ID: 27490478
[TBL] [Abstract][Full Text] [Related]
42. Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Srivastava RK; Shankar S
Cancer Lett; 2014 Oct; 353(1):32-40. PubMed ID: 25050737
[TBL] [Abstract][Full Text] [Related]
43. Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract.
Damhofer H; Ebbing EA; Steins A; Welling L; Tol JA; Krishnadath KK; van Leusden T; van de Vijver MJ; Besselink MG; Busch OR; van Berge Henegouwen MI; van Delden O; Meijer SL; Dijk F; Medema JP; van Laarhoven HW; Bijlsma MF
J Transl Med; 2015 Apr; 13():115. PubMed ID: 25884700
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
[TBL] [Abstract][Full Text] [Related]
45. Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.
Chaudary N; Pintilie M; Hedley D; Hill RP; Milosevic M; Mackay H
Br J Cancer; 2017 Jan; 116(1):50-57. PubMed ID: 27875522
[TBL] [Abstract][Full Text] [Related]
46. Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin.
Friedbichler K; Hofmann MH; Kroez M; Ostermann E; Lamche HR; Koessl C; Borges E; Pollak MN; Adolf G; Adam PJ
Mol Cancer Ther; 2014 Feb; 13(2):399-409. PubMed ID: 24296829
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic silencing of sonic hedgehog elicits antitumor immune response and suppresses tumor growth by inhibiting the hedgehog signaling pathway in metastatic spine tumors in Sprague-Dawley rats.
Shi G; Zhang H; Yu Q; Jin H; Hu CM; Li SC; Ji YB
J Cell Biochem; 2018 Nov; 119(11):9591-9603. PubMed ID: 30191602
[TBL] [Abstract][Full Text] [Related]
48. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
49. Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
Lubik AA; Nouri M; Truong S; Ghaffari M; Adomat HH; Corey E; Cox ME; Li N; Guns ES; Yenki P; Pham S; Buttyan R
Int J Cancer; 2017 Jan; 140(2):358-369. PubMed ID: 27672740
[TBL] [Abstract][Full Text] [Related]
50. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
Li QR; Zhao H; Zhang XS; Lang H; Yu K
Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
[TBL] [Abstract][Full Text] [Related]
51. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
[TBL] [Abstract][Full Text] [Related]
52. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
53. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
54. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
55. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
[TBL] [Abstract][Full Text] [Related]
56. Non-cell-autonomous signaling by Shh in tumors: challenges and opportunities for therapeutic targets.
Bijlsma MF; Roelink H
Expert Opin Ther Targets; 2010 Jul; 14(7):693-702. PubMed ID: 20515293
[TBL] [Abstract][Full Text] [Related]
57. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
58. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer.
Fukaya M; Isohata N; Ohta H; Aoyagi K; Ochiya T; Saeki N; Yanagihara K; Nakanishi Y; Taniguchi H; Sakamoto H; Shimoda T; Nimura Y; Yoshida T; Sasaki H
Gastroenterology; 2006 Jul; 131(1):14-29. PubMed ID: 16831586
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling.
Tang B; Xu A; Xu J; Huang H; Chen L; Su Y; Zhang L; Li J; Fan F; Deng J; Tang L; Sun C; Hu Y
Int J Cancer; 2018 Jan; 142(1):109-120. PubMed ID: 28905994
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of sonic hedgehog and PI3K/Akt/mTOR pathways cooperate in suppressing survival, self-renewal and tumorigenic potential of glioblastoma-initiating cells.
Nanta R; Shrivastava A; Sharma J; Shankar S; Srivastava RK
Mol Cell Biochem; 2019 Apr; 454(1-2):11-23. PubMed ID: 30251117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
